EU Looks to Bolster Future Health Response Amid Vaccine Snags
- Ursula von der Leyen held call with pharmaceutical executives
- Call aimed to launch work on European bio-defense preparedness
This article is for subscribers only.
The European Union said it’s taking steps to bolster its pandemic preparedness, citing the risk posed by Covid variants that reduce the efficacy of vaccines.
European Commission President Ursula von der Leyen on Sunday held a video call with chief executives of pharmaceutical companies including AstraZeneca Plc and Moderna Inc. to discuss how vaccines could be more rapidly deployed, manufactured and approved in the future.